GLACEUM
Latest round
- Series D
Last raised
- Nov 2019
Total raised
- $25M
Investors
- 6
About GLACEUM
Based in South Korea, and founded in 2014, GLACEUM, INC. develops therapeutic drugs for retinal and inflammatory diseases and also treats obesity., Ltd. The transaction values the company at KRW 200 billion post-money. The company offer metabolic syndrome drug and therapy for the treatment of metabolic diseases including nonalcoholic steatohepatitis (NASH). The business specializes in treating conditions including obesity, diabetes, and fatty liver by focusing on the mitochondria, a crucial organelle that produces energy and synthesizes important chemicals associated with inflammation.
Who invested in GLACEUM
6 investors across 4 rounds
See all investors in GLACEUM
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GLACEUM
Who invested in GLACEUM?
GLACEUM has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GLACEUM raised?
GLACEUM has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did GLACEUM last raise money?
GLACEUM's most recent round on record is a Series D, in Nov 2019.
What does GLACEUM do?
Based in South Korea, and founded in 2014, GLACEUM, INC.
Where is GLACEUM headquartered?
GLACEUM is headquartered in Gyeonggi-do, South Korea.
Which VCs invest in companies like GLACEUM?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at GLACEUM's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like GLACEUM? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.